Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
Cologuard Plus™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Exact Sciences Corp
Type:
FDA Approved
Related tests:
‹
Resolution ctDx FIRST Assay (1)
CancerSEEK
Cancerguard™
Cologuard®
OncoExTra™ test
Oncoguard® Esophagus Test
Oncoguard™ Liver
Oncomap™ ExTra test
Oncotype DX AR-V7 Nucleus Detect® test
Oncotype DX Breast DCIS Score test
Oncotype DX Breast Recurrence Score®Test
Oncotype DX® Colon Recurrence Score test
Oncotype MAP™ Pan-Cancer Tissue Test
Resolution HRD assay
Resolution ctDx Lung Assay™
Riskguard™ Hereditary Cancer Test
Resolution ctDx FIRST Assay (1)
CancerSEEK
Cancerguard™
Cologuard®
OncoExTra™ test
Oncoguard® Esophagus Test
Oncoguard™ Liver
Oncomap™ ExTra test
Oncotype DX AR-V7 Nucleus Detect® test
Oncotype DX Breast DCIS Score test
Oncotype DX Breast Recurrence Score®Test
Oncotype DX® Colon Recurrence Score test
Oncotype MAP™ Pan-Cancer Tissue Test
Resolution HRD assay
Resolution ctDx Lung Assay™
Riskguard™ Hereditary Cancer Test
›
Details
Evidence
News
Cologuard Plus is highly sensitive for detecting colorectal cancer.
Cancer:
Colorectal Cancer
Method:
Next-Generation Sequencing (NGS)
Approvals
Date
Cancer
Gene
Biomarker
Drug
Approved by
10/04/2024
Colorectal Cancer
-
-
FDA Approved
Approvals
Date
Cancer
Gene
Drug
By
10/04/24
CRC
-
FDA
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login